1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow ixabepilone + cetuximab: new trials by email Literature Review of ixabepilone + cetuximab trials Research Report on ixabepilone + cetuximab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Randomized Phase II Study of Ixabepilone Alone and Ixabepilone Plus Cetuximab as First-Line Treatment for Female Subjects With Triple Negative Locally Advanced Non-resectable and/or Metastatic Breast Cancer ixabepilone, ixabepilone + cetuximab - Triple Negative Locally Advanced Non-resectable Breast Cancer, Metastatic Breast Cancer | Phase 2 | Completed | R-Pharm | 79 | 2008-06-01 | 2016-03-10 |
Breast Neoplasms (1)
R-Pharm (1)
Austria (1) · Czechia (1) · France (1) · Greece (1) · Italy (1) · Poland (1) · Spain (1)